{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+%28SOC%29&page=3", "query": { "intervention": "Standard of Care (SOC)", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 1108, "total_pages": 111, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+%28SOC%29&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+%28SOC%29&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T06:57:24.080Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07162194", "title": "MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prostate Carcinoma" ], "interventions": [ { "name": "Targeted Prostate Biopsy", "type": "PROCEDURE" }, { "name": "Prostate Imaging Reporting & Data System", "type": "DIAGNOSTIC_TEST" }, { "name": "Deep Learning Artificial Intelligence", "type": "DIAGNOSTIC_TEST" }, { "name": "Green Learning Artificial Intelligence", "type": "DIAGNOSTIC_TEST" }, { "name": "Radical Prostatectomy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DIAGNOSTIC_TEST" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Years", "maximum_age": null, "sex": "MALE", "summary": "20 Years and older · Male only" }, "enrollment_count": 130, "start_date": "2025-09-19", "completion_date": "2028-10-15", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07162194" }, { "nct_id": "NCT05799755", "title": "Myositis Interstitial Lung Disease Nintedanib Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Myositis Associated Interstitial Lund Disease (MA-ILD)" ], "interventions": [ { "name": "Nintedanib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of Care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rohit Aggarwal, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2023-08-01", "completion_date": "2025-12-31", "has_results": true, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Denver, Colorado + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Denver", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05799755" }, { "nct_id": "NCT05228821", "title": "Voxelotor Brain Oxygenation and Neurocognitive Study", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sickle Cell Disease" ], "interventions": [ { "name": "Voxelotor Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "12 Years to 30 Years" }, "enrollment_count": 0, "start_date": "2023-08-09", "completion_date": "2023-08-23", "has_results": false, "last_update_posted_date": "2024-08-09", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 2, "location_summary": "St Louis, Missouri • The Bronx, New York", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05228821" }, { "nct_id": "NCT04579393", "title": "Fostamatinib for Hospitalized Adults With COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronavirus Disease 2019" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "fostamatinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2020-10-08", "completion_date": "2021-04-30", "has_results": true, "last_update_posted_date": "2022-03-02", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 2, "location_summary": "Bethesda, Maryland • Falls Church, Virginia", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Falls Church", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04579393" }, { "nct_id": "NCT05007106", "title": "MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Uterine Cervical Neoplasms", "Endometrial Neoplasms", "Squamous Cell Carcinoma of Head and Neck", "Gallbladder Neoplasms", "Cholangiocarcinoma", "Esophageal Neoplasms", "Triple Negative Breast Neoplasms", "Hepatocellular Carcinoma", "Urinary Bladder Neoplasms", "Ovarian Neoplasms", "Stomach Neoplasms" ], "interventions": [ { "name": "Pembrolizumab/Vibostolimab Co-Formulation", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Lenvatinib", "type": "DRUG" }, { "name": "5-Fluorouracil", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 611, "start_date": "2021-09-16", "completion_date": "2025-08-05", "has_results": true, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 14, "location_summary": "Anchorage, Alaska • Duarte, California • Orange, California + 11 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Duarte", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Basking Ridge", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05007106" }, { "nct_id": "NCT06979362", "title": "A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "CDR132L", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "40 Years to 84 Years" }, "enrollment_count": 200, "start_date": "2025-06-27", "completion_date": "2028-07-25", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Covina, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06979362" }, { "nct_id": "NCT07110142", "title": "Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Oral Cancer", "Head and Neck Cancer" ], "interventions": [ { "name": "Tongueometer", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2025-12-10", "completion_date": "2029-06", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07110142" }, { "nct_id": "NCT01670461", "title": "FAmily CEntered (FACE) Advance Care Planning for Teens With Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "FACE", "type": "BEHAVIORAL" }, { "name": "Standard of Care (SOC) Control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Maureen Lyon", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "14 Years to 90 Years" }, "enrollment_count": 60, "start_date": "2009-01", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2019-03-08", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01670461" }, { "nct_id": "NCT04829461", "title": "Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystoscopy", "Ureteral Stent" ], "interventions": [ { "name": "Ambu® aScope™ 4 Cysto with the aView™ 2 Advance used for stent removal", "type": "DEVICE" }, { "name": "Standard of care reusable cystoscope used for stent removal", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Ambu Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 102, "start_date": "2021-04-27", "completion_date": "2022-07-20", "has_results": true, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 3, "location_summary": "Hershey, Pennsylvania • Dallas, Texas • Madison, Wisconsin", "locations": [ { "city": "Hershey", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04829461" }, { "nct_id": "NCT07230340", "title": "Nonhealing Venous Leg Ulcers Treated With a Standard of Care (SoC) Alone or Standard of Care and Dehydrated Human Placenta Tissue (dHPT) With Crossover", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Venous Leg Ulcer (VLU)" ], "interventions": [ { "name": "Amnion-Intermediate-Chorion", "type": "OTHER" }, { "name": "Standard of Care (SOC)", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "Cellution Biologics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2026-02-04", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-17T06:57:24.080Z", "location_count": 1, "location_summary": "Rocky Mount, North Carolina", "locations": [ { "city": "Rocky Mount", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07230340" } ] }